Skip to main content
Anthony D'Amico, MD, Radiology, Missoula, MT

Anthony D'Amico MD FASTRO

Neuroradiology


Professor of Radiation Oncology, Brigham and Women's Hospital

Join to View Full Profile
  • 3205 S Russell StMissoula, MT 59801

  • Phone+1 406-721-4906

  • Fax+1 406-447-7916

Are you Dr. D'Amico?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

  • Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Summary

  • Dr. Anthony D'Amico, MD is a board certified radiologist in Missoula, Montana. He is currently licensed to practice medicine in Montana, Washington, and Arizona. He is a Professor of Radiation Oncology at Brigham and Women's Hospital.

Education & Training

  • University of Michigan
    University of MichiganFellowship, Neuroradiology, 2007 - 2008
  • University of Michigan
    University of MichiganResidency, Radiology-Diagnostic, 2003 - 2007
  • University of Washington
    University of WashingtonInternship, Internal Medicine, 2002 - 2003
  • University of Washington School of Medicine
    University of Washington School of MedicineClass of 2002

Certifications & Licensure

  • MT State Medical License
    MT State Medical License 2007 - 2025
  • WA State Medical License
    WA State Medical License 2017 - 2025
  • AZ State Medical License
    AZ State Medical License 2007 - 2010
  • OH State Medical License
    OH State Medical License 2007 - 2009
  • TN State Medical License
    TN State Medical License 2007 - 2009
  • IL State Medical License
    IL State Medical License 2007 - 2008
  • KY State Medical License
    KY State Medical License 2007 - 2008
  • Diagnostic Radiology
    American Board of Radiology Diagnostic Radiology
  • Neuroradiology
    American Board of Radiology Neuroradiology
  • Join now to see all

Publications & Presentations

PubMed

Press Mentions

  • New Findings Could Change Treatment Practice and Lengthen Survival for Men with pN1 Prostate Cancer
    New Findings Could Change Treatment Practice and Lengthen Survival for Men with pN1 Prostate CancerMarch 15th, 2022
  • Anthony D'Amico, MD, on Docetaxel in Men with Unfavorable-Risk Prostate Cancer
    Anthony D'Amico, MD, on Docetaxel in Men with Unfavorable-Risk Prostate CancerNovember 3rd, 2021
  • Anthony D'Amico, MD, PhD, on Adjuvant vs Early Salvage RT
    Anthony D'Amico, MD, PhD, on Adjuvant vs Early Salvage RTSeptember 22nd, 2021
  • Join now to see all